TCL Archive NCS Heeds Bloch’s Plea, To Consider Establishing Separate PDQ-Like System For General Public Use December 7, 1984
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
